NDAINJECTIONINJECTABLEPriority Review
Approved
Oct 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 57m ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PAVULON (pancuronium bromide) is a long-acting neuromuscular blocking agent administered via injection for use during anesthesia and mechanical ventilation. It works by competitively blocking acetylcholine at the neuromuscular junction, causing skeletal muscle paralysis. The drug is used to facilitate intubation and maintain muscle relaxation during surgical procedures and critical care.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure, brand teams focus on cost management and generic transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PAVULON offers experience in legacy product management, generic transition strategy, and healthcare economics in anesthesia. The role emphasizes cost optimization, market defense, and operational efficiency rather than growth-stage innovation.
Brand ManagerProduct Manager
Worked on PAVULON at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.